{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T06:57:54Z","timestamp":1772348274321,"version":"3.50.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate ocular angiographic features of hereditary transthyretin amyloidosis with transthyretin Val30Met mutation (hATTR-V30M) in Japanese patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively reviewed 102 eyes of 51 patients with hATTR-V30M who underwent fluorescein angiograms and indocyanine green angiograms between 2012 and 2018. Systemic severity score, fluorescein angiograms, indocyanine green angiograms, and ocular amyloidosis presentations at the final angiograms and subsequent neovascular events were evaluated. Primary outcomes were the frequency of choroidal amyloid angiopathy and retinal amyloid angiopathy (RAA). Secondary outcomes were their correlations to the systemic severity score.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Six eyes could not be evaluated by fluorescein angiogram because of vitreous opacity. Of 96 eyes evaluated, RAA was detected in 36 (37.5%). Neovascularization was not detected. Indocyanine green angiogram indicated choroidal amyloid angiopathy in 46\/51 patients (90.2%), with distinct patterns\u2015diffuse (n = 6), focal (n = 14), and punctiform (n = 26)\u2015based on late-phase hypercyanescence. Retinal amyloid angiopathy and choroidal amyloid angiopathy grades were associated with systemic severity (<jats:italic toggle=\"yes\">\u03c1<\/jats:italic> = 0.57 and 0.50, respectively; both <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). At 35.4 \u00b1 28.4 (0\u201396) months, iris-rubeosis was observed in one eye and vitreous hemorrhage in two.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Retinal amyloid angiopathy was less common and choroidal amyloid angiopathy was frequent, and their severity correlated with the systemic severity score. The frequencies of RAA and subsequent neovascular events in this study may suggest regional differences in the ocular angiographic features of hATTR-V30M.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003291","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T19:29:10Z","timestamp":1630956550000},"page":"210-215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["OCULAR ANGIOGRAPHIC FEATURES IN JAPANESE PATIENTS WITH VAL30MET HEREDITARY TRANSTHYRETIN AMYLOIDOSIS"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8433-8169","authenticated-orcid":false,"given":"Shinji","family":"Kakihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yorishige","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruyoshi","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plante-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2169\/internalmedicine.44.1151","article-title":"Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations","volume":"44","author":"Takei","year":"2005","journal-title":"Intern Med"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.58.7.1001","article-title":"Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity","volume":"58","author":"Ikeda","year":"2002","journal-title":"Neurology"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archophthalmol.2009.390","article-title":"Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients","volume":"128","author":"Hara","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/13506129.2018.1554563","article-title":"Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis","volume":"26","author":"Buxbaum","year":"2019","journal-title":"Amyloid"},{"key":"R11-20250607","article-title":"Specific postoperative complications of vitrectomy in hereditary transthyretin amyloidosis","author":"Thiagasorupan","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bjophthalmol-2019-315381","article-title":"Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis","volume":"104","author":"Bunod","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2018.05.023","article-title":"Angiographic signatures of the predominant form of familial transthyretin amyloidosis (Val30Met mutation)","volume":"192","author":"Rousseau","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10384-020-00753-0","article-title":"Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy","volume":"64","author":"Kakihara","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/s41598-020-62559-x","article-title":"Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis","volume":"10","author":"Kakihara","year":"2020","journal-title":"Sci Rep"},{"key":"R16-20250607","article-title":"Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis","author":"Marta","year":"2021","journal-title":"Eye"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2017.09.001","article-title":"Ocular manifestations of familial transthyretin amyloidosis","volume":"183","author":"Reynolds","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ophtha.2017.03.011","article-title":"Vitreous amyloidosis: ocular, systemic, and genetic insights","volume":"124","author":"Venkatesh","year":"2017","journal-title":"Ophthalmology"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0021-5155(02)00626-3","article-title":"Choroidal vascular lesions identified by ICG angiography in a case of familial amyloidotic polyneuropathy","volume":"47","author":"Kojima","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2005.05.028","article-title":"Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C","volume":"112","author":"Kawaji","year":"2005","journal-title":"Ophthalmology"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/IAE.0000000000002961","article-title":"Association between choroidal characteristics and systemic severity in amyloidosis","volume":"41","author":"Mano","year":"2021","journal-title":"Retina"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/13506129.2012.724035","article-title":"Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly","volume":"19","author":"Levy","year":"2012","journal-title":"Amyloid"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/ICB.0b013e3182681259","article-title":"The use of intravitreal ranibizumab to treat neovascular glaucoma because of retinal amyloid angiopathy in familial amyloidosis transthyretin v30m related","volume":"7","author":"Beir\u00e3o","year":"2013","journal-title":"Retin Cases Brief Rep"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1442-9071.2002.00539.x","article-title":"Familial amyloidotic polyneuropathy presenting with rubeotic glaucoma","volume":"30","author":"Dunlop","year":"2002","journal-title":"Clin Exp Ophthalmol"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.oret.2020.12.028","article-title":"Deposits on retinal surface seen on OCT in ocular amyloidosis","volume":"5","author":"Kakihara","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(02)01838-X","article-title":"Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy","volume":"135","author":"Koga","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/13506129.2015.1015678","article-title":"Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases","volume":"22","author":"Beir\u00e3o","year":"2015","journal-title":"Amyloid"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/13506129.2010.527068","article-title":"Transthyretin-related vitreous amyloidosis in different endemic areas","volume":"17","author":"Kawaji","year":"2010","journal-title":"Amyloid"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/13506129.2018.1531842","article-title":"Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan","volume":"25","author":"Ueda","year":"2018","journal-title":"Amyloid"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ophtha.2009.07.042","article-title":"Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation","volume":"117","author":"Kawaji","year":"2010","journal-title":"Ophthalmology"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:06:32Z","timestamp":1749319592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003291","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}